Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion type Assertion NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_head.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion description "[PI3K pathway mutations co-occurred with BRAF(V600) mutations in 17% of the tumors and co-occurred with 9% of NRAS mutant tumors, implying cooperativity between these pathways in terms of melanoma progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_provenance.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion evidence source_evidence_literature NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_provenance.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion SIO_000772 22912864 NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_provenance.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion wasDerivedFrom befree-2016 NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_provenance.
- NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_assertion wasGeneratedBy ECO_0000203 NP1007263.RAcrpz1hzm3B6WIN-BWcve6y-Kf4bMYYSUfvu2hHRStRA130_provenance.